Consolidated Balance Sheets (Current Period Unaudited) - USD ($) $ in Thousands		Sep. 30, 2021	Dec. 31, 2020
Assets
Unrestricted cash and cash equivalents		$ 166,966	$ 178,102
Restricted cash and cash equivalents		47,808	80,859
Loans, interest and fees receivable:
Loans, interest and fees receivable, at fair value		846,160	417,098
Loans, interest and fees receivable, gross		511,140	667,556
Allowances for uncollectible loans, interest and fees receivable (including $76.8 million and $120.9 million associated with variable interest entities at September 30, 2021 and December 31, 2020, respectively)		(80,029)	(124,961)
Deferred revenue (including $7.4 million and $10.3 million associated with variable interest entities at September 30, 2021 and December 31, 2020, respectively)		(29,824)	(39,456)
Net loans, interest and fees receivable		1,247,447	920,237
Property at cost, net of depreciation		984	2,240
Investments in equity-method investee		0	1,415
Operating lease right-of-use assets		5,447	9,181
Prepaid expenses and other assets		14,292	15,180
Total assets		1,482,944	1,207,214
Liabilities
Accounts payable and accrued expenses		38,627	41,731
Operating lease liabilities		7,231	13,776
Notes Payable, net held by VIEs		995,322	882,610
Notes payable associated with structured financings, at fair value (associated with variable interest entities)		2,221	2,919
Convertible senior notes		0	24,386
Income tax liability		38,016	25,932
Total liabilities		1,081,417	991,354
Commitments and contingencies (Note 11)
Shareholders' Equity
Common stock, no par value, 150,000,000 shares authorized: 16,553,615 and 16,115,353 shares issued at September 30, 2021 and December 31, 2020, respectively; 15,094,382 and 16,115,353 (including 1,459,233 loaned shares to be returned) shares outstanding at September 30, 2021 and December 31, 2020, respectively		0	0
Paid-in capital		252,438	194,950
Retained earnings (deficit )		10,259	(117,666)
Treasury stock, 1,459,233 and 0 shares at September 30, 2021 and December 31, 2020, respectively, at cost		0	0
Total shareholders’ equity		262,697	77,284
Noncontrolling interests		(745)	(774)
Total equity		261,952	76,510
Total liabilities, preferred stock and shareholders' equity		1,482,944	1,207,214
Series A Preferred Stock [Member]
Liabilities
Preferred stock	[1]	40,000	40,000
Preferred stock	[1]	40,000	40,000
Series B Preferred Stock [Member]
Liabilities
Preferred stock		99,575	99,350
Preferred stock		99,575	99,350
Shareholders' Equity
Series B preferred stock, no par value, 3,188,533 shares issued and outstanding at September 30, 2021 and 0 shares issued and outstanding at December 31, 2020 (liquidation preference - $79.7 million) (1)	[1]	$ 0	$ 0

[1] Both the Series A preferred stock and the Series B preferred stock have no par value and are part of the same aggregate 10,000,000 shares authorized.